Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTheworks.co.uk. Regulatory News (WRKS)

Share Price Information for Theworks.co.uk. (WRKS)

Share Price is delayed by 15 minutes
Get Live Data
66.60    -0.40 (-0.60%)
Bid:
65.00
Ask:
67.00
Spread: 2.00 (3.077%)
Market Cap: £39.54m
WRKS Live PriceLast checked at - London Stock Exchange

Intraday Theworks.co.uk. Share Chart

Director/PDMR Shareholding

30 Sep 2021 16:42

RNS Number : 6214N
TheWorks.co.uk PLC
30 September 2021
 

TheWorks.co.uk plc

(the "Company")

Director/PDMR Shareholding

TheWorks.co.uk plc, the multi-channel value retailer of gifts, arts, crafts, toys, books and stationery, today announces that on 30 September 2021, the Company granted awards over ordinary shares of 1 pence each in the Company under the TheWorks.co.uk 2018 Long Term Incentive Plan ("LTIP Award") as follows:

 

Name of individual

Position / status

Type of award

Number of shares subject to LTIP Award

Gavin Peck

Chief Executive Officer

LTIP Award - nil cost option

638,297

Stephen Alldridge

Chief Financial Officer

LTIP Award - nil cost option

446,808

 

The vesting of the LTIP Award is subject to the achievement of performance targets as set out below:

 

Measure

Weighting

Threshold (20% vesting)

Maximum (100% vesting)

EPS1

50%

5.6 pence

15.6 pence

Share Price2

50%

£0.57

£2

1Basic EPS for the company's 2023/2024 financial year, pre-IFRS16 and subject to such adjustments as the Remuneration Committee determines to ensure that performance is assessed on a fair and consistent basis

2Average share price over the period of four weeks beginning with the announcement by the company of its Full Year Trading Update for its 2023/2024 financial year.

 

The whole LTIP Award is subject to an underpin condition in accordance with which the Remuneration Committee may adjust the formulaic vesting outturn having regard to the overall financial performance of the group over the performance period and whether any value in the LTIP Award at assessment of the performance condition represents a "windfall gain".

 

The LTIP Award will vest following the assessment of the performance conditions (to the extent that the conditions have been satisfied) and, in accordance with the Company's Remuneration Policy, then be subject to a further two year holding period.

 

The notifications below, made in accordance with the requirements of the UK Market Abuse Regulation, provide further detail:

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Gavin Peck

2.

Reason for notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

TheWorks.co.uk plc

b)

LEI

894500W7PWBCCWBN9R03

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument;(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of £0.01 each

 

ISIN: GB00BF5HBF20

b)

Nature of the transaction

Grant of nil-cost options over ordinary shares under the Company's Long Term Incentive Plan

c)

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

Nil cost award

638,297

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

N/A - single transaction

 

e)

Date of the transaction

2021-09-30

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Stephen Alldridge

2.

Reason for notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

TheWorks.co.uk plc

b)

LEI

894500W7PWBCCWBN9R03

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument;(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of £0.01 each

 

ISIN: GB00BF5HBF20

b)

Nature of the transaction

Grant of nil-cost options over ordinary shares under the Company's Long Term Incentive Plan

c)

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

Nil cost award

446,808

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

N/A - single transaction

 

e)

Date of the transaction

2021-09-30

f)

Place of the transaction

Outside a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVEAAIIVIL
Date   Source Headline
26th May 20267:00 amRNS-RInvestor Event - Mello London
22nd May 20267:00 amRNSHolding(s) in Company
21st May 20267:00 amRNSTrading update for the 52 weeks ended 3 May 2026
29th Apr 20269:53 amRNSHolding(s) in Company
24th Apr 20265:55 pmRNSHolding(s) in Company
23rd Apr 20267:00 amRNSHolding(s) in Company
15th Apr 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20264:20 pmRNSHolding(s) in Company
20th Mar 20267:00 amRNSUpdate regarding online proposition
27th Feb 20265:36 pmRNSHolding(s) in Company
25th Feb 20267:00 amRNSDirectorate Change
22nd Jan 20267:00 amRNSInterim results and Christmas trading update
15th Jan 20267:00 amRNSNotice of Results and Investor Presentation
8th Dec 202511:52 amRNSHolding(s) in Company
27th Nov 20252:19 pmRNSDirectorate Change
13th Nov 20257:04 amRNSDirectorate Change
13th Nov 20257:00 amRNSHalf-year trading update
12th Sep 20253:53 pmRNSDirector/PDMR Shareholding
8th Sep 20252:40 pmRNSResult of AGM
8th Sep 20257:00 amRNSAGM Trading Statement
7th Aug 20251:09 pmRNSPublication of Annual Report and Notice of AGM
1st Aug 20257:00 amRNSDirectorate Change
22nd Jul 20257:00 amRNSPreliminary results - 52 weeks ended 4 May 2025
15th Jul 20257:00 amRNSNotice of Results and Investor Presentation
22nd May 20257:00 amRNSFull Year Trading Update
29th Apr 202512:00 pmRNSDirector/PDMR Shareholding
24th Apr 20257:52 amRNSDirector/PDMR Shareholding
11th Apr 20257:00 amRNSDirector/PDMR Shareholding
8th Apr 20257:00 amRNSPurchase of Shares for the Employee Benefit Trust
6th Feb 202512:39 pmRNSHolding(s) in Company
4th Feb 20252:59 pmRNSHolding(s) in Company
31st Jan 20257:00 amRNSDirector/PDMR Shareholding
24th Jan 20257:00 amRNSH1 FY25 results, Christmas trading & new strategy
17th Jan 20257:00 amRNSNotice of Results and Investor Presentation
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSDirectorate Change
31st Oct 202410:00 amRNSResult of AGM and Notice of 2024 Interim Results
8th Oct 202411:09 amRNSNotice of AGM and Publication of Annual Report
3rd Oct 20249:00 amRNSPurchase of Shares for the Employee Benefit Trust
1st Oct 20243:59 pmRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSDirectorate Change
1st Oct 20247:00 amRNSPreliminary results - 53 weeks ended 5 May 2024
23rd Sep 20247:00 amRNSNotice of Results and Investor Presentation
5th Sep 202411:45 amRNSHolding(s) in Company
7th Aug 20246:03 pmRNSHolding(s) in Company
1st Aug 20247:00 amRNSDirectorate Change
15th Jul 20249:58 amRNSHolding(s) in Company
12th Jul 20248:44 amRNSDirector/PDMR Shareholding
4th Jul 202410:50 amRNSHolding(s) in Company
2nd Jul 20247:02 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.